Integrating Human and Mouse Studies in Fragile X Syndrome – an NIH Center Approach

Integrating Human and Mouse Studies in Fragile X Syndrome – an NIH Center Approach
FRAXA Seminar Series This virtual seminar series addresses a wide range of current topics in Fragile X research. Hosted by FRAXA and organized by Michael Tranfaglia, MD and Patricia Cogram, PhD, sessions feature outstanding speakers from universities and the biotech and pharmaceutical industries.  Presentation Summary Craig Erickson - Translational medicine and mechanistic studies of brain neurophysiology in Fragile X Syndrome: A NIH Center Overview Ernest Pedapati - Network Mechanisms, Biomarkers, and Pharmacology of Fragile X Syndrome in Humans Devin Binder - Network Mechanisms of Neurophysiology and Behavior in mouse models of Fragile X Syndrome Kimberly Huber - FMRP Regulation of local and long-range neocortical circuits in the mouse: Links with EEG phenotypes About the SpeakersCraig A. Erickson, MD Professor of Psychiatry at Cincinnati Children's Hospital and the University of Cincinnati College of Medicine Craig Erickson is the director of the Cincinnati Fragile X Research and Treatment Center. Craig has devoted his careerRead more

Gene Therapy Translational Studies for Fragile X Syndrome

Gene Therapy Translational Studies for Fragile X Syndrome

With this $90,000 award from FRAXA Research Foundation, Drs. Ernest Pedapati, Christina Gross, and student Lindsay Beasley will pursue preclinical gene therapy approaches using AAV (adeno-associated virus) vectors for treating Fragile X syndrome at Cincinnati Children’s Hospital. Dr. Craig Erickson elaborates about this in this video.

Read more